Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...

Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It allows physicians to deliver chemotherapy directly to the liver at doses up ...

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine respectively, have each been recently awarded $300,000 in grants under the Rivkin ...